Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Common Equity (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Common Equity for 2 consecutive years, with $164.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 169.37% to $164.1 million in Q4 2025 year-over-year; TTM through Oct 2025 was $164.1 million, a 169.37% increase, with the full-year FY2025 number at $205.4 million, up 198.1% from a year prior.
  • Common Equity was $164.1 million for Q4 2025 at Kestra Medical Technologies, down from $184.2 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $205.4 million in Q2 2025 to a low of -$236.5 million in Q4 2024.